Does dose modification affect efficacy of first-line pazopanib in metastatic renal cell carcinoma?

被引：0
|
作者：
Fuca, G. [1 ]
Verzoni, E. [1 ]
Ratta, R. [1 ]
Luca, P. [2 ]
Martinetti, A. [2 ]
Mennitto, A. [1 ]
Grassi, P. [1 ]
Procopio, G. [1 ]
机构：
[1] IRCCS Fdn Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[2] Mario Negri Inst Pharmacol Res, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B11
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
    Paolo Grassi
    Elena Verzoni
    Raffaele Ratta
    Luca Porcu
    Michele Prisciandaro
    Alessia Mennitto
    Giuseppina Calareso
    Filippo de Braud
    Giuseppe Procopio
    [J]. Drugs in R&D, 2017, 17 : 461 - 467
  • [2] Does dose modification affect efficacy of first-line pazopanib in metastatic renal cell carcinoma?
    Grassi, Paolo
    Procopio, Giuseppe
    Ratta, Raffaele
    Porcu, Luca
    Martinetti, Antonia
    Mennitto, Alessia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [3] Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
    Grassi, Paolo
    Verzoni, Elena
    Ratta, Raffaele
    Porcu, Luca
    Prisciandaro, Michele
    Mennitto, Alessia
    Calareso, Giuseppina
    de Braud, Filippo
    Procopio, Giuseppe
    [J]. DRUGS IN R&D, 2017, 17 (03) : 461 - 467
  • [4] First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience
    Lalani, Aly-Khan A.
    Li, Haocheng
    Heng, Daniel Y. C.
    Wood, Lori
    Kalirai, Austin
    Bjarnason, Georg A.
    Sim, Hao-Wen
    Kollmannsberger, Christian K.
    Kapoor, Anil
    Hotte, Sebastien J.
    Vanhuyse, Marie
    Czaykowski, Piotr
    Reaume, M. Neil
    Soulieres, Denis
    Venner, Peter
    North, Scott
    Basappa, Naveen S.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (3-4): : 112 - 117
  • [5] Broad immunomodulating effect of first-line Pazopanib in metastatic renal cell carcinoma patients
    Verzoni, E.
    Cova, A.
    Squarcina, P.
    De Cecco, L.
    Rinchai, D.
    Bedognetti, D.
    Grassi, P.
    Ratta, R.
    Procopio, G.
    Rivoltini, L.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [6] Economic evaluation of pazopanib as first-line treatment of metastatic renal cell carcinoma in Greece
    Solakidi, A.
    Kourlaba, G.
    Kontovinis, L.
    Bournakis, E.
    Boutis, A.
    Koutsoukos, K.
    Syrios, J.
    Tzovaras, A.
    Chatzikou, M.
    Michailidi, C.
    Maniadakis, N.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [7] Broad immunomodulating effect of first-line pazopanib in metastatic renal cell carcinoma patients
    Verzoni, E.
    De Cecco, L.
    Dugo, M.
    Rinchai, D.
    Bedognetti, D.
    Grassi, P.
    Ratta, R.
    Cova, A.
    Squarcina, P.
    Huber, V.
    Montone, R.
    Sorrentino, M.
    Procopio, G.
    Rivoltini, L.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [8] The efficacy of axitinib as a first-line treatment for metastatic renal cell carcinoma
    Kameda, Tomohiro
    Takayama, Tatsuya
    Sugihara, Toru
    Takeshima, Saki
    Yamazaki, Masahiro
    Komatsubara, Maiko
    Kamei, Jun
    Fujisaki, Akira
    Ando, Satoshi
    Kurokawa, Shinsuke
    Fujimura, Tetsuya
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (04) : 241 - 246
  • [9] Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian Population
    Velho, Pedro Isaacsson
    Nardo, Mirella
    Leonardde Azevedo Souza, Manoel Carlos
    Colombo Bonadio, Renata R. C.
    Marta, Guilherrne Nader
    Muniz, David Q. B.
    Bastos, Diogo Assed
    Dzik, Carlos
    [J]. JOURNAL OF GLOBAL ONCOLOGY, 2018, 4
  • [10] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Ruiz-Morales, Jose Manuel
    Swierkowski, Marcin
    Wells, J. Connor
    Fraccon, Anna Paola
    Pasini, Felice
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Sim, Hao-Wen
    Sliwczynsk, Andrzej
    Ptak-Chmielewska, Aneta
    Teter, Zbigniew
    Beuselinck, Benoit
    Wood, Lori A.
    Yuasa, Takeshi
    Pezaro, Carmel
    Rini, Brian I.
    Szczylik, Cezary
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 65 : 102 - 108
12345